Total Payments
$116,859
2024 Payments
$144.54
Companies
20
Transactions
216
Payment Breakdown by Category
Other$101,290 (86.7%)
Travel$5,728 (4.9%)
Consulting$5,002 (4.3%)
Food & Beverage$4,840 (4.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $92,590 | 59 | 79.2% |
| Honoraria | $8,700 | 7 | 7.4% |
| Travel and Lodging | $5,728 | 27 | 4.9% |
| Consulting Fee | $5,002 | 6 | 4.3% |
| Food and Beverage | $4,840 | 117 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Greenwich Biosciences, Inc. | $79,517 | 125 | $0 (2021) |
| Neurelis, Inc. | $12,789 | 20 | $0 (2021) |
| BioMarin Pharmaceutical Inc. | $8,540 | 17 | $0 (2019) |
| Zogenix Inc. | $5,600 | 7 | $0 (2020) |
| Upsher-Smith Laboratories LLC | $3,639 | 3 | $0 (2018) |
| BIOCODEX, INC. | $2,631 | 4 | $0 (2019) |
| UCB GmBH | $1,165 | 9 | $0 (2019) |
| PTC Therapeutics, Inc. | $1,000 | 1 | $0 (2018) |
| Zimmer Biomet Holdings, Inc. | $959.03 | 8 | $0 (2019) |
| NEUROPACE, INC. | $335.49 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $144.54 | 1 | JAZZ PHARMACEUTICALS INC. ($144.54) |
| 2023 | $88.87 | 1 | Jazz Pharmaceuticals Inc. ($88.87) |
| 2021 | $3,917 | 4 | Greenwich Biosciences, Inc. ($2,706) |
| 2020 | $39,983 | 76 | Greenwich Biosciences, Inc. ($22,675) |
| 2019 | $59,410 | 111 | Greenwich Biosciences, Inc. ($54,136) |
| 2018 | $13,096 | 20 | BioMarin Pharmaceutical Inc. ($8,308) |
| 2017 | $219.18 | 3 | BioMarin Pharmaceutical Inc. ($120.23) |
All Payment Transactions
216 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $144.54 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2023 | Jazz Pharmaceuticals Inc. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $88.87 | General |
| Category: NEUROLOGY | ||||||
| 04/13/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $11.08 | General |
| Category: PSYCHOLOGY | ||||||
| 03/05/2021 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: EPILEPSY | ||||||
| 03/03/2021 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,353.00 | General |
| Category: Neurology | ||||||
| 02/22/2021 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,353.00 | General |
| Category: Neurology | ||||||
| 12/22/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: Neurology | ||||||
| 12/21/2020 | Zogenix Inc. | Fintepla (Drug) | Honoraria | Cash or cash equivalent | $500.00 | General |
| Category: Treatment of seizures | ||||||
| 12/17/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Food and Beverage | In-kind items and services | $32.28 | General |
| Category: Neurology | ||||||
| 12/16/2020 | Zogenix Inc. | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: Treatment of seizures | ||||||
| 12/11/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Food and Beverage | In-kind items and services | $37.72 | General |
| Category: Neurology | ||||||
| 12/09/2020 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: EPILEPSY | ||||||
| 12/08/2020 | Zogenix Inc. | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Treatment of seizures | ||||||
| 11/23/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Neurology | ||||||
| 11/20/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Neurology | ||||||
| 11/17/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Neurology | ||||||
| 11/14/2020 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: EPILEPSY | ||||||
| 11/11/2020 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: EPILEPSY | ||||||
| 11/11/2020 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $31.46 | General |
| Category: EPILEPSY | ||||||
| 10/28/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Neurology | ||||||
| 10/23/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Neurology | ||||||
| 10/22/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Neurology | ||||||
| 10/21/2020 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: EPILEPSY | ||||||
| 10/21/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Neurology | ||||||
| 10/20/2020 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Neurology | ||||||
About Dr. Ian Miller, MD
Dr. Ian Miller, MD is a Clinical Neurophysiology healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1811189061.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ian Miller, MD has received a total of $116,859 in payments from pharmaceutical and medical device companies, with $144.54 received in 2024. These payments were reported across 216 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($92,590).
Ad
Practice Information
- Specialty Clinical Neurophysiology
- Other Specialties Neurology with Special Qualifications in Child Neurology
- Location Miami, FL
- Active Since 08/13/2007
- Last Updated 12/11/2020
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1811189061
Products in Payments
- Epidiolex (Drug) $79,517
- VALTOCO (Drug) $12,789
- Brineura (Biological) $8,468
- Fintepla (Drug) $5,600
- VIGADRONE (vigabatrin) for Oral Solution (Drug) $3,639
- DIACOMIT (Drug) $2,631
- Vimpat (Drug) $1,165
- ROSA (Device) $959.03
- RNS System (Device) $335.49
- EPIDIOLEX (Drug) $233.41
- Briviact (Drug) $181.67
- Neuroblate (Device) $129.79
- Vimizim (Biological) $42.07
- Fycompa (Drug) $31.95
- Strensiq (Drug) $24.21
- ACTHAR (Biological) $23.66
- INGREZZA (Drug) $18.55
- VNS Therapy (Device) $15.17
- SYMPAZAN (Drug) $14.20
- QELBREE (Drug) $11.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Neurophysiology Doctors in Miami
Marytery Fajardo, M.d, M.D
Clinical Neurophysiology — Payments: $28,793
Clinical Neurophysiology $28,793
Isabella Ferando, Md, Phd, MD, PHD
Clinical Neurophysiology — Payments: $2,377
Clinical Neurophysiology $2,377
Jose Simon Canellas, Md, MD
Clinical Neurophysiology — Payments: $2,036
Clinical Neurophysiology $2,036
Dr. Naiara Garcia Losarcos, M.d, M.D
Clinical Neurophysiology — Payments: $483.45
Clinical Neurophysiology $483.45